loadpatents
name:-0.050122976303101
name:-0.032054901123047
name:-0.0028350353240967
Fasano; Alessio Patent Filings

Fasano; Alessio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fasano; Alessio.The latest application filed is for "monitoring and altering the gut microbiome in disease".

Company Profile
2.30.48
  • Fasano; Alessio - Boston MA
  • Fasano; Alessio - Baltimore MD
  • Fasano; Alessio - West Friendship MD
  • Fasano; Alessio - Charlestown MA US
  • Fasano; Alessio - Ellicott City MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Monitoring And Altering The Gut Microbiome In Disease
App 20220218761 - Leonard; Maureen M. ;   et al.
2022-07-14
Biosensors in Human Gut Organoids
App 20200308549 - Fasano; Alessio ;   et al.
2020-10-01
Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress syndrome
Grant 10,723,763 - Paterson , et al.
2020-07-28
Materials And Methods For The Treatment Of Celiac Disease
App 20160375089 - Fasano; Alessio ;   et al.
2016-12-29
Use Of Tight Junction Antagonists In The Treatment Of Acute Lung Injury And Acute Respiratory Distress
App 20160355551 - Paterson; Blake ;   et al.
2016-12-08
Methods And Compositions For The Diagnosis Of Crohn's Disease
App 20160349257 - Bai; Julio ;   et al.
2016-12-01
Methods And Compositions For The Diagnosis Of Crohn's Disease
App 20160109444 - Bai; Julio ;   et al.
2016-04-21
Use Of Tight Junction Antagonists In The Treatment Of Acute Lung Injury And Acute Respiratory Distress
App 20160106803 - Paterson; Blake ;   et al.
2016-04-21
Materials and methods for the treatment of celiac disease
Grant 9,279,807 - Fasano , et al. March 8, 2
2016-03-08
Multicellular organotypic model of human intestinal mucosa
Grant 9,200,258 - Mezghanni , et al. December 1, 2
2015-12-01
EGFR and PAR2 Regulation of Intestinal Permeability
App 20140363818 - Fasano; Alessio ;   et al.
2014-12-11
Method And Use Of Peptide Antagonists Of Zonulin To Prevent Or Delay The Onset Of Diabetes
App 20140128321 - Fasano; Alessio ;   et al.
2014-05-08
Peptide Antagonists Of Zonulin And Methods For Use Of The Same
App 20140128328 - Fasano; Alessio
2014-05-08
Methods And Compositions For The Diagnosis Of Crohn's Disease
App 20130295594 - Bai; Julio ;   et al.
2013-11-07
Use Of Tight Junction Antagonists In The Treatment Of Acute Lung Injury And Acute Respiratory Distress
App 20130288950 - Paterson; Blake ;   et al.
2013-10-31
Peptide Antagonists Of Zonulin And Methods For Use Of The Same
App 20130190247 - Fasano; Alessio
2013-07-25
Method And Use Of Peptide Antagonists Of Zonolin To Prevent Or Delay The Onset Of Diabetes
App 20130157943 - Fasano; Alessio ;   et al.
2013-06-20
Antibacterial Lactobacillus GG peptides and methods of use
Grant 8,431,528 - Lu , et al. April 30, 2
2013-04-30
Multicellular Organotypic Model Of Human Intestinal Mucosa
App 20120196275 - MEZGHANNI; Rosangela ;   et al.
2012-08-02
Pharmaceutical compositions for inhibiting intestinal permeability
Grant 8,183,211 - Fasano May 22, 2
2012-05-22
EGFR and PAR2 Regulation of Intestinal Permeability
App 20120107329 - Fasano; Alessio ;   et al.
2012-05-03
Materials And Methods For The Treatment Of Celiac Disease
App 20120076861 - FASANO; Alessio ;   et al.
2012-03-29
Materials and methods for the treatment of celiac disease
Grant 8,034,776 - Fasano , et al. October 11, 2
2011-10-11
Use Of Tight Junction Antagonists In The Treatment Of Acute Lung Injury And Acute Respiratory Distress
App 20110201543 - Paterson; Blake ;   et al.
2011-08-18
Peptide Antagonists Of Zonulin And Methods For Use Of The Same
App 20110183923 - FASANO; Alessio
2011-07-28
Antibacterial lactobacillus GG peptides and methods of use
App 20110105385 - Lu; Ruiliang ;   et al.
2011-05-05
Agonist polypeptide of receptor for ZOT and zonulin
Grant 7,777,001 - Fasano , et al. August 17, 2
2010-08-17
Pharmaceutical Compositions For Inhibiting Intestinal Permeability
App 20100087380 - FASANO; Alessio ;   et al.
2010-04-08
Use Of Tight Junction Agonists To Facilitate Pulmonary Delivery Of Therapeutic Agents
App 20090297559 - FASANO; Alessio ;   et al.
2009-12-03
Methods for screening for modulators of CXCR3 signaling
Grant 7,622,264 - Fasano , et al. November 24, 2
2009-11-24
Method for treating or inhibiting intestinal inflammation
Grant 7,582,603 - Fasano September 1, 2
2009-09-01
Methods And Compositions For The Diagnosis Of Crohn's Disease
App 20090176244 - BAI; Julio ;   et al.
2009-07-09
Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
Grant 7,531,512 - Fasano , et al. May 12, 2
2009-05-12
Pharmaceutical composition and method for inhibiting gastrointestinal inflammation
Grant 7,531,504 - Fasano May 12, 2
2009-05-12
Peptide Antagonists Of Zonulin And Methods For Use Of The Same
App 20090082279 - Fasano; Alessio
2009-03-26
Method Of Use Of Peptide Antagonists Of Zonulin To Prevent Or Delay The Onset Of Diabetes
App 20080269136 - Fasano; Alessio ;   et al.
2008-10-30
Agonist Polypeptide Of Receptor For Zot And Zonulin
App 20080113918 - Fasano; Alessio ;   et al.
2008-05-15
Materials And Methods For The Treatment Of Celiac Disease
App 20080103100 - Fasano; Alessio ;   et al.
2008-05-01
Peptide Antagonists Of Zonulin And Methods For Use Of The Same
App 20080051349 - Fasano; Alessio
2008-02-28
Method Of Diagnosing Celiac Disease
App 20080038843 - Fasano; Alessio ;   et al.
2008-02-14
Use Of Tight Junction Agonists To Facilitate Pulmonary Delivery Of Therapeutic Agents
App 20080014218 - Fasano; Alessio ;   et al.
2008-01-17
Agonist polypeptide of receptor for Zot and Zonulin
Grant 7,294,689 - Fasano , et al. November 13, 2
2007-11-13
Oral Delivery Of Therapeutic Agents Using Tight Junction Agonists
App 20070196272 - Eddington; Natalie D. ;   et al.
2007-08-23
Peptide antagonists of zonulin and methods for use of the same
Grant 7,189,696 - Fasano March 13, 2
2007-03-13
CXCR3 is a gliadin receptor
App 20070048801 - Fasano; Alessio ;   et al.
2007-03-01
Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
App 20060287233 - Fasano; Alessio ;   et al.
2006-12-21
Peptide antagonists of zonulin and methods for use of the same
App 20060276399 - Fasano; Alessio
2006-12-07
Agonist polypeptide of receptor for ZOT and zonulin
App 20060276403 - Fasano; Alessio ;   et al.
2006-12-07
Method of assessing the effectiveness of a treatment regimen
App 20060269968 - Fasano; Alessio
2006-11-30
Peptides for delivery of mucosal vaccines
App 20060165722 - De Magistris; Maria Teresa ;   et al.
2006-07-27
Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
App 20060128626 - Fasano; Alessio ;   et al.
2006-06-15
Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
Grant 7,026,294 - Fasano , et al. April 11, 2
2006-04-11
Peptide antagonists of zonulin and methods for use of the same
App 20050209161 - Fasano, Alessio
2005-09-22
Peptide antagonists of zonulin and methods for use of the same
Grant 6,936,689 - Fasano August 30, 2
2005-08-30
Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
App 20050065074 - Fasano, Alessio ;   et al.
2005-03-24
Agonist polypeptide of receptor for Zot and Zonulin
App 20050059593 - Fasano, Alessio ;   et al.
2005-03-17
Methods Of Identifying Bacterial Genes That Are Incompatible With Bacterial Pathogenicity, And The Use Of Such Genes, Such As Cada, To Reduce Pathogenicity In A Bacteria Or To Combat Pathogenic Bacterial Infections
Grant 6,780,414 - Maurelli , et al. August 24, 2
2004-08-24
Method of using Zot to inhibit lymphocyte proliferation in an antigen-specific manner
Grant 6,733,762 - Fasano , et al. May 11, 2
2004-05-11
Peptide antagonists of zonulin and methods for use of the same
App 20040082512 - Fasano, Alessio
2004-04-29
Peptide antagonists of zonulin and methods for use of the same
Grant 6,670,448 - Fasano December 30, 2
2003-12-30
Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cadA, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections
App 20020192225 - Maurelli, Anthony T. ;   et al.
2002-12-19
Peptide antagonists of zonulin and methods for use of the same
Grant 6,458,925 - Fasano October 1, 2
2002-10-01
Peptide antagonists of zonulin and methods for use of the same
App 20020115825 - Fasano, Alessio
2002-08-22
Zonula occludens toxic receptor
Grant 5,948,629 - Fasano September 7, 1
1999-09-07
Substantially pure zonulin, a physiological modulator of mammalian tight junctions
Grant 5,945,510 - Fasano August 31, 1
1999-08-31
Zonula occludens toxin receptors
Grant 5,912,323 - Fasano June 15, 1
1999-06-15
Dosage composition for nasal delivery and method of use of the same
Grant 5,908,825 - Fasano , et al. June 1, 1
1999-06-01
Zonula occludens toxin receptor
Grant 5,864,014 - Fasano January 26, 1
1999-01-26
Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery
Grant 5,827,534 - Fasano October 27, 1
1998-10-27
Antibodies having binding specificity to ShET2, an enterotoxin of Shigella flexneri 2A
Grant 5,686,580 - Fasano , et al. November 11, 1
1997-11-11
Oral dosage composition for intestinal delivery and method of treating diabetes
Grant 5,665,389 - Fasano September 9, 1
1997-09-09
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed